Shimadzu Corp. Stock Hits Day Low of JPY 3,820 Amid Price Pressure

Shimadzu Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 3.48% on March 4, 2026, reaching an intraday low of JPY 3,820.00. This performance stands in contrast to the Japan Nikkei 225, which fell by 1.12% on the same day. Over the past week, Shimadzu Corp. has seen a significant drop of 10.73%, while its one-month performance reflects a decrease of 10.17%. Year-to-date, the stock has declined by 7.56%, underperforming the Nikkei 225, which has gained 12.88% during the same period. Despite these challenges, Shimadzu Corp. maintains a strong management efficiency, highlighted by a return on equity (ROE) of 11.12% and a low debt-to-equity ratio of -0.29. However, the company has faced a decline in profits, with a reported decrease of 3.7% over the past year, while its stock has generated a modest return of 1.09%. The current price reflects a premium valuation with a price-to-book ratio of 2.51, indicating that the stock is trading at a higher level compared to its peers.